TOBREXAN
TOBREXAN
Discontinued
DIN Number
02261243
Drug Class
Human
Market Date
N/A
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02261243
AIG Number0110230005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01AA12 TOBRAMYCIN
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:04.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
TOBRAMYCINActive
Strength: 0.3 % / W/V
Monograph: TOBRAMYCIN